Please login to the form below

Moderna

This page shows the latest Moderna news and features for those working in and with pharma, biotech and healthcare.

UK pharmacies to begin administering COVID-19 vaccinations

The UK has already approved three COVID-19 vaccines: Pfizer/BioNTech’s mRNA-based vaccine, AstraZeneca(AZ)/Oxford University’s vaccine and most recently Moderna’s vaccine. ... While people in the UK have already been receiving the Pfizer/BioNTech

Latest news

AZ seeks EU approval for its Oxford University-partnered COVID-19 vaccine

Earlier this month, Moderna’s COVID-19 vaccine was granted a swift approval from the EC, just a day after the jab received a positive opinion from the CHMP.
New NHS COVID-19 vaccination centres open as cases surge in the UK

The UK has already approved three COVID-19 vaccines: Pfizer/BioNTech’s mRNA-based vaccine, AstraZeneca(AZ)/Oxford University’s jab and most recently Moderna’s vaccine.. ... While people in the UK have already been receiving the Pfizer/BioNTech and
UK approves Moderna’s COVID-19 vaccine, secures another 10 million doses

Following the approval, the UK has secured an additional 10 million doses of Moderna’s COVID-19 vaccine, taking its total to 17 million doses. ... Pfizer/BioNTech and Moderna's vaccines must be kept at low temperatures of -70 C and -20 C respectively.
Moderna’s COVID-19 vaccine could offer protection for ‘a couple of years’, says CEO

Moderna’s chief executive officer (CEO) Stéphane Bancel has said that the company’s COVID-19 vaccine could offer protection for "potentially a couple of years”. ... Although additional data is required, Bancel’s comments demonstrate a confidence
Pfizer/BioNTech vaccine shown to be effective against new COVID-19 variants

Other COVID-19 vaccine developers, such as Moderna, havewith similar confidence. Moderna previously told Bloomberg it expects its mRNA-based vaccine is likely to be effective against the new UK strain.

More from news
Approximately 35 fully matching, plus 82 partially matching documents found.

Latest Intelligence

COVID-19: the race to find a vaccine

Moderna was the first group to test a vaccine in humans, using its mRNA platform to enter the clinic in record time. ... Moderna thinks its vaccine could be available to healthcare professionals as early as the autumn, but the accepted timeline for
Developing a COVID-19 vaccine

At the front of the race is Cambridge, Massachusetts-based biotech company Moderna, which dosed the first patient in the US in March with its COVID-19 vaccine candidate. ... To win approval for public use, a larger phase 2 trial is need, which Moderna
Deal Watch September 2016

Abbott, Allergan, Celgene, Moderna, Pfizer and Takeda feature in this month's pharma deals round-up. ... up. Turning to the battle against the Zika virus, BARDA announced three more grants for vaccine development to Takeda (up to $312m), Moderna [up to
Deal Watch June 2016

Apart from the $200m upfront cash payment to Moderna, there were no other financials disclosed. ... licence. 230. Moderna Therapeutics/ Merck &Co. mRNA-based personalised cancer vaccines; exclusive for Keytruda combinations (discovery).
Deal Watch October 2015

Whilst considering nucleic acid-based approaches, it was interesting to see that mRNA company Moderna Therapeutics, which has a number of deals under its belt with AstraZeneca, Alexion and Merck &Co, ... This is Moderna's fourth venture in what it calls

More from intelligence
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest appointments

Ex-Roche CMO Sandra Horning joins Gilead’s board of directors

Horning has also recently joined the board of directors at Moderna, a clinical-stage biotechnology company based in Cambridge, Massachusetts.
Tony de Fougerolles joins Evox Therapeutics as CEO

Prior to this, he was chief scientific officer at Moderna Therapeutics and has held the same role at Tolerx.
Medicxi appoints former GSK chair Moncef Slaoui

Dr Slaoui takes on the role alongside his other board positions, which include chairman of the board at Galvani Bioelectronics, and on the boards of Artisan Biosciences, Moderna Therapeutics and Sutovax.
MIT chief financial officer joins Moderna Therapeutics

US-based biotech Moderna Therapeutics has appointed Israel Ruiz to its board of directors to serve as audit committee chair. ... Dr Noubar Afeyan, co-founder and chairman of Moderna Therapeutics, said: “We are delighted to welcome Israel to Moderna's
PureTech Health appoints chief scientific officer

Bringing over 30 years of clinical development experience to the role, he joins from Moderna Therapeutics where he most recently served as president and chief scientific officer.

More from appointments
Approximately 3 fully matching, plus 6 partially matching documents found.

Latest from PMHub

Is the world ready for a COVID-19 vaccine?

Since then, other good news has followed, with collaborations, including Moderna and AstraZeneca, publishing similarly positive results. ... Since this initial announcement, other good news in vaccine development has followed, with companies and
Hanover Communications

Since then, other good news has followed, with collaborations, including Moderna and AstraZeneca, publishing similarly positive results.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Medical Editor: Competitive

Account Manager Healthcare / Pharmaceutical Sector: Negotiable Salary

Healthcare Senior Account Manager: Competitive

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Healthcare Account Director: Competitive

Account Director – Creative Healthcare Communications: Competative

Healthcare Lead Copywriter: Competitive

PMHub

Add my company

JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

AstraZeneca’s focus on diagnosing and managing chronic kidney disease: People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story: How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
Three ways AI will change healthcare in the next decade: Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...